Value judgments for priority setting criteria in genetic testing: A discrete choice experiment
- 1 February 2015
- journal article
- Published by Elsevier in Health Policy
- Vol. 119 (2) , 164-173
Abstract
No abstract availableKeywords
Funding Information
- European Society of Human Genetics and the Genetic Alliance UK
- EuroGentest2
- EU-FP7 (HEALTH-F4-2010-261469)
- German Federal Ministry of Education and Research (BMBF) (01GP1006A-C)
This publication has 26 references indexed in Scilit:
- Patient Preferences Versus Physicians’ Judgement: Does it Make a Difference in Healthcare Decision Making?Applied Health Economics and Health Policy, 2013
- Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experimentsEuropean Journal of Human Genetics, 2013
- The EuroGentest Clinical Utility Gene CardsEuropean Journal of Human Genetics, 2010
- A Framework for the Prioritization of Investment in the Provision of Genetic TestsPublic Health Genomics, 2010
- The $1,000 genome, the $100,000 analysis?Genome Medicine, 2010
- Challenges of translating genetic tests into clinical and public health practiceNature Reviews Genetics, 2009
- Technology assessment and resource allocation for predictive genetic testing: A study of the perspectives of Canadian genetic health care providersBMC Medical Ethics, 2009
- EuroGentest: DNA-Based Testing for Heritable Disorders in EuropePublic Health Genomics, 2008
- Current impact of gene technology on healthcareHealth Policy, 2007
- DNA-based Genetic Testing Is Rising Steeply in a National Health Care System with Open Access to Services: A Survey of Genetic Test Use in Germany, 1996–2002Genetic Testing, 2005